Theravance Biopharma presents at H.C. Wainwright conference; no material financial updates in slide deck

Theravance Biopharma, Inc.

Management team to participate in fireside chat and one-on-one meetings at H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024.
Slide presentation furnished as Exhibit 99.1 contains no new financial guidance or operational data beyond prior disclosures.
Filing is a procedural Regulation FD disclosure for investor presentation; no earnings, M&A, or leadership changes announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.